NWL
48
4
URBN
67
3
UPS
51
6
FOX
71
3
BIIB
36
8
NWSA
69
4
IP
53
3
ESS
44
5
FCX
44
4
HBAN
47
7
EQR
33
6
APH
53
3
MU
42
14
CAH
44
7
BAX
38
2
CHRW
53
2
PRU
39
3
FSLR
50
6
HSY
32
3
NRG
32
5
NWL
48
4
URBN
67
3
UPS
51
6
FOX
71
3
BIIB
36
8
NWSA
69
4
IP
53
3
ESS
44
5
FCX
44
4
HBAN
47
7
EQR
33
6
APH
53
3
MU
42
14
CAH
44
7
BAX
38
2
CHRW
53
2
PRU
39
3
FSLR
50
6
HSY
32
3
NRG
32
5
Financhill
Back

Energy Recovery 10K Form

Sell
40

ERII
Energy Recovery

Last Price:
$15.14
Seasonality Move:
-5.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ERII News And Ratings

See the #1 stock for the next 7 days that we like better than ERII

ERII Financial Statistics

Sales & Book Value

Annual Sales: $128.3M
Cash Flow: $-3.2M
Price / Cash Flow: 38.31
Annual Sales: $4.04
Price / Book: 3.75

Profitability

EPS (TTM): 0.34000
Net Income (TTM): $19.4M
Gross Margin: $87.1M
Return on Equity: 8.96%
Return on Assets: 7.87%

Energy Recovery Earnings Forecast

Key Energy Recovery Financial Ratios

  • The Gross Profit Margin over the past 21 years for ERII is 67.85%.
  • The Selling, General & Administrative Expenses for ERII have been equal to 39.76% of Gross Profit Margin.
  • The Research & Development expenses have been 13.25% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of ERII is 16.75% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 12 years.

Energy Recovery Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Machinery
Sector: Industrials
Current Symbol: ERII
CUSIP: 29270J
Website: energyrecovery.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 10.06
Quick Ratio: 7.97

Price-to-Earnings

Trailing P/E Ratio: 40.92
Forward P/E Ratio: 22.02

ERII Technical Analysis vs Fundamental Analysis

Sell
40
Energy Recovery (ERII) is a Sell

Is Energy Recovery a Buy or a Sell?

  • Energy Recovery stock is rated a Sell
    The current Energy Recovery [ERII] share price is $15.14. The Score for ERII is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.